SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-042522
Filing Date
2018-11-06
Accepted
2018-11-06 16:31:23
Documents
66
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 827701
2 EXHIBIT 10.4 ex10_4.htm EX-10.4 118264
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 13075
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 13052
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6219
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 6207
  Complete submission text file 0001140361-18-042522.txt   4593094

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aqst-20180930.xml EX-101.INS 667197
8 XBRL TAXONOMY EXTENSION SCHEMA aqst-20180930.xsd EX-101.SCH 47083
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqst-20180930_cal.xml EX-101.CAL 46477
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqst-20180930_def.xml EX-101.DEF 211562
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20180930_lab.xml EX-101.LAB 596708
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20180930_pre.xml EX-101.PRE 333177
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 181163429
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1